This is one more reason flat-across-doses pricing matters: the dose is likely to change, and a price that follows it introduces uncertainty into a multi-year budget
Enhanced pharmacovigilance frameworks will be instrumental in maintaining patient safety
For example, increased level of galectin-3-binding protein (responsible for cancer development, progression and metastasis) inflammatory markers (IFN-, IFN-, IFN-, TNF-), trombospondin-1(increased in tumors and associated with thrombosis), -1-acid glycoprotein-2 (associated with demyelinating diseases), and reduced levels of long palate, lung and nasal epithelium carcinoma-associated protein 1, lactotransferrin, adiponectin and -1-acid glycoprotein-1 may be the result of immunosuppression similar to that of sepsis
It is not a GLP-1-only agonist, but it is often discussed alongside GLP-1 medications because many of the benefits and side effects overlap
Access this article Similar content being viewed by others Data availability The data that support the findings of this study are available from the corresponding author upon reasonable request